Abstract Acute Respiratory Distress Syndrome (ARDS) is one of the most demanding
conditions in an Intensive Care Unit (ICU). Management of analgesia and sedation in ARDS …

The rapid spread of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
has led to a global pandemic. The 2019 coronavirus disease (COVID-19) presents with a …

Rationale: Sevoflurane improves gas exchange, and reduces alveolar edema and
inflammation in preclinical studies of lung injury, but its therapeutic effects have never been …

Inhaled anesthetics have been in clinical use for over 150 years and are still commonly used
in daily practice. The initial view of inhaled anesthetics as indispensable for general …

Hospitals worldwide are experiencing a shortage in essential intravenous sedative
medications. This is attributable to high number and high sedative needs of COVID-19 …

Evolving targets for sedation during mechanical ventilation : Current Opinion in Critical Care
Evolving targets for sedation during mechanical ventilation : Current Opinion in Critical Care …

Inhaled sedation with halogenated agents, such as isoflurane or sevoflurane, is now
feasible in intensive care unit (ICU) patients through dedicated vaporisers and scavenging …

Objectives: The ongoing coronavirus pandemic is challenging, especially in severely
affected patients who require intubation and sedation. Although the potential benefits of …

Background Current intensive care unit (ICU) sedation guidelines recommend strategies
using non-benzodiazepine sedatives. This survey was undertaken to explore inhaled ICU …

Inhaled sedation was recently approved in Europe as an alternative to intravenous sedative
drugs for intensive care unit (ICU) sedation. The aim of this narrative review was to …